We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (383)
- Scheduling (national classification system) (164)
- Safety monitoring and information (26)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Medicinal cannabis hub (6)
- Clinical trials (5)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
758 result(s) found, displaying 1 to 25
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 31 July 2025
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulation 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations).
-
Meeting statementsAdvisory Committee on Vaccines meeting statement 54
-
Meeting statementsMedical device reforms: Consumer Working Group meeting statement, Meeting 17, 22 August 2025
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsThe 87th meeting of the Advisory Committee on Medical Devices (ACMD) was held on 9 October 2025.
-
Meeting statementsCommunique from the 10th meeting of the WHPWG, 17 July 2025
-
Meeting statementsFind out about the AIVC Recommendations for the Composition of Influenza Vaccines for Australia in 2026.
-
TGA laboratory testing reportsThe Therapeutic Goods Administration (TGA) is issuing a safety advisory regarding imported unregistered melatonin products following testing by TGA Laboratories.
-
Scheduling decisions (final)Publication of the decisions made by a delegate of the Secretary
-
TGA laboratory testing reportsIn response to increased adverse event reports, the TGA has investigated Vyvanse products, which included laboratory testing to assess the quality of the 6 different strengths of Vyvanse products.
-
Meeting statementsCommunique from the 3rd meeting of the Human Research Ethics Committee and TGA Clinical Trials Discussion Forum, 13 August 2025
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 6 March 2025
-
TGA laboratory testing reportsThis study by the TGA assesses the particle filtration efficiency of respirators listed in the ARTG or submitted for compliance testing during the COVID-19 pandemic.
-
Meeting statementsThe 86th meeting of the Advisory Committee on Medical Devices (ACMD) was held on 14 August 2025.
-
TGA laboratory testing reportsFace masks that are intended by their manufacturer to prevent the transmission of diseases between people or are intended to be used in a healthcare environment, are medical devices
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
TGA laboratory testing reportsTGA laboratories Branch tested various seasonal influenza vaccine batches.
-
TGA laboratory testing reportsBetween November 2024 and April 2025, TGA, Laboratories Branch tested various Heparin products
-
Meeting statementsAdvisory Committee on Vaccines meeting statement 53
-
TGA laboratory testing reportsThis report summarises the extensive batch release testing activities undertaken by the TGA Laboratories for COVID-19 mRNA vaccines.
-
TGA laboratory testing reportsThis survey focused on single-ingredient vitamin D3 products with high sales volumes in Australia between January and December 2023. The TGA tested 13 of the top-selling products, which were supplied by nine different sponsors.
-
Corporate reportsThe Australian Sunscreen Exposure Model performs sunscreen exposure calculations that reflect the unique conditions and practices in Australia.
-
Meeting statementsCommunique from the 9th meeting of the WHPWG 27 March 2025
-
Corporate reportsRead our business plan 2025-26 to find out about our strategic priorities and activities.